3-[(21E)-3-(2-amino-2-oxoethyl)-28-(12-chlorotetradecan-2-yl)-21-ethylidene-27-hydroxy-18-(1-hydroxyethyl)-6-(1-methoxyethyl)-4-methyl-2,5,8,11,14,17,20,23,26,30-decaoxo-15,24-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,29-decazabicyclo[29.3.0]tetratriacontan-12-yl]propanamide
| Internal ID | e170cfd7-edf2-4506-b2b3-d90b38e32a95 |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides > Cyclic peptides |
| IUPAC Name | 3-[(21E)-3-(2-amino-2-oxoethyl)-28-(12-chlorotetradecan-2-yl)-21-ethylidene-27-hydroxy-18-(1-hydroxyethyl)-6-(1-methoxyethyl)-4-methyl-2,5,8,11,14,17,20,23,26,30-decaoxo-15,24-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,29-decazabicyclo[29.3.0]tetratriacontan-12-yl]propanamide |
| SMILES (Canonical) | CCC(CCCCCCCCCC(C)C1C(C(=O)NC(C(=O)NC(=CC)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)N(C(C(=O)N2CCCC2C(=O)N1)CC(=O)N)C)C(C)OC)CCC(=O)N)C(C)C)C(C)O)C(C)C)O)Cl |
| SMILES (Isomeric) | CCC(CCCCCCCCCC(C)C1C(C(=O)NC(C(=O)N/C(=C/C)/C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)N(C(C(=O)N2CCCC2C(=O)N1)CC(=O)N)C)C(C)OC)CCC(=O)N)C(C)C)C(C)O)C(C)C)O)Cl |
| InChI | InChI=1S/C57H97ClN12O15/c1-12-35(58)23-20-18-16-14-15-17-19-22-32(7)45-48(75)55(82)66-44(31(5)6)52(79)62-36(13-2)50(77)68-46(33(8)71)54(81)65-43(30(3)4)53(80)63-37(25-26-40(59)72)49(76)61-29-42(74)64-47(34(9)85-11)57(84)69(10)39(28-41(60)73)56(83)70-27-21-24-38(70)51(78)67-45/h13,30-35,37-39,43-48,71,75H,12,14-29H2,1-11H3,(H2,59,72)(H2,60,73)(H,61,76)(H,62,79)(H,63,80)(H,64,74)(H,65,81)(H,66,82)(H,67,78)(H,68,77)/b36-13+ |
| InChI Key | QEQPUTKQRURHAG-FIFHTESVSA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C57H97ClN12O15 |
| Molecular Weight | 1225.90 g/mol |
| Exact Mass | 1224.6884881 g/mol |
| Topological Polar Surface Area (TPSA) | 409.00 Ų |
| XlogP | 2.80 |
| Atomic LogP (AlogP) | -0.74 |
| H-Bond Acceptor | 15 |
| H-Bond Donor | 12 |
| Rotatable Bonds | 22 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.8825 | 88.25% |
| Caco-2 | - | 0.8609 | 86.09% |
| Blood Brain Barrier | - | 0.7250 | 72.50% |
| Human oral bioavailability | - | 0.7714 | 77.14% |
| Subcellular localzation | Mitochondria | 0.5288 | 52.88% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8069 | 80.69% |
| OATP1B3 inhibitior | + | 0.9149 | 91.49% |
| MATE1 inhibitior | - | 0.9600 | 96.00% |
| OCT2 inhibitior | - | 0.8567 | 85.67% |
| BSEP inhibitior | + | 0.9435 | 94.35% |
| P-glycoprotein inhibitior | + | 0.7422 | 74.22% |
| P-glycoprotein substrate | + | 0.8852 | 88.52% |
| CYP3A4 substrate | + | 0.7446 | 74.46% |
| CYP2C9 substrate | - | 0.8016 | 80.16% |
| CYP2D6 substrate | - | 0.8678 | 86.78% |
| CYP3A4 inhibition | - | 0.8242 | 82.42% |
| CYP2C9 inhibition | - | 0.8087 | 80.87% |
| CYP2C19 inhibition | - | 0.8014 | 80.14% |
| CYP2D6 inhibition | - | 0.8905 | 89.05% |
| CYP1A2 inhibition | - | 0.8273 | 82.73% |
| CYP2C8 inhibition | + | 0.7685 | 76.85% |
| CYP inhibitory promiscuity | - | 0.9752 | 97.52% |
| UGT catelyzed | - | 0.5000 | 50.00% |
| Carcinogenicity (binary) | - | 0.6700 | 67.00% |
| Carcinogenicity (trinary) | Non-required | 0.5144 | 51.44% |
| Eye corrosion | - | 0.9823 | 98.23% |
| Eye irritation | - | 0.8966 | 89.66% |
| Skin irritation | - | 0.7529 | 75.29% |
| Skin corrosion | - | 0.9012 | 90.12% |
| Ames mutagenesis | - | 0.6037 | 60.37% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.6449 | 64.49% |
| Micronuclear | + | 0.7900 | 79.00% |
| Hepatotoxicity | - | 0.5802 | 58.02% |
| skin sensitisation | - | 0.8514 | 85.14% |
| Respiratory toxicity | + | 0.7667 | 76.67% |
| Reproductive toxicity | + | 0.9000 | 90.00% |
| Mitochondrial toxicity | + | 0.7625 | 76.25% |
| Nephrotoxicity | + | 0.5640 | 56.40% |
| Acute Oral Toxicity (c) | III | 0.6144 | 61.44% |
| Estrogen receptor binding | + | 0.6954 | 69.54% |
| Androgen receptor binding | + | 0.7097 | 70.97% |
| Thyroid receptor binding | + | 0.5511 | 55.11% |
| Glucocorticoid receptor binding | + | 0.6910 | 69.10% |
| Aromatase binding | + | 0.7178 | 71.78% |
| PPAR gamma | + | 0.7827 | 78.27% |
| Honey bee toxicity | - | 0.6686 | 66.86% |
| Biodegradation | - | 0.8000 | 80.00% |
| Crustacea aquatic toxicity | - | 0.5276 | 52.76% |
| Fish aquatic toxicity | + | 0.7033 | 70.33% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.81% | 96.09% |
| CHEMBL2581 | P07339 | Cathepsin D | 99.27% | 98.95% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 98.72% | 94.45% |
| CHEMBL1937 | Q92769 | Histone deacetylase 2 | 97.56% | 94.75% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 96.67% | 82.38% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 96.66% | 90.08% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 96.43% | 83.82% |
| CHEMBL2443 | P49862 | Kallikrein 7 | 96.42% | 94.00% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 96.41% | 91.11% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 96.36% | 94.66% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 95.83% | 95.50% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 95.82% | 97.25% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 95.82% | 95.89% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 95.45% | 93.00% |
| CHEMBL4071 | P08311 | Cathepsin G | 94.90% | 94.64% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 94.85% | 90.17% |
| CHEMBL333 | P08253 | Matrix metalloproteinase-2 | 94.70% | 96.31% |
| CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 94.31% | 91.03% |
| CHEMBL3837 | P07711 | Cathepsin L | 93.10% | 96.61% |
| CHEMBL3524 | P56524 | Histone deacetylase 4 | 92.71% | 92.97% |
| CHEMBL226 | P30542 | Adenosine A1 receptor | 92.46% | 95.93% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 91.87% | 90.71% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 91.14% | 95.00% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 89.60% | 97.09% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 89.53% | 100.00% |
| CHEMBL1902 | P62942 | FK506-binding protein 1A | 89.41% | 97.05% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 88.15% | 96.47% |
| CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 87.84% | 98.75% |
| CHEMBL325 | Q13547 | Histone deacetylase 1 | 87.75% | 95.92% |
| CHEMBL5203 | P33316 | dUTP pyrophosphatase | 87.46% | 99.18% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 87.32% | 95.56% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 87.31% | 96.90% |
| CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 | 87.12% | 97.43% |
| CHEMBL228 | P31645 | Serotonin transporter | 87.00% | 95.51% |
| CHEMBL332 | P03956 | Matrix metalloproteinase-1 | 86.57% | 94.50% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 86.55% | 100.00% |
| CHEMBL4005 | P42336 | PI3-kinase p110-alpha subunit | 85.82% | 97.47% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 85.37% | 93.03% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 85.03% | 97.64% |
| CHEMBL213 | P08588 | Beta-1 adrenergic receptor | 84.42% | 95.56% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 84.24% | 85.14% |
| CHEMBL344 | Q99705 | Melanin-concentrating hormone receptor 1 | 84.16% | 92.50% |
| CHEMBL2096618 | P11274 | Bcr/Abl fusion protein | 84.06% | 85.83% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 83.74% | 95.71% |
| CHEMBL2007 | P16234 | Platelet-derived growth factor receptor alpha | 83.71% | 91.07% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 83.59% | 88.56% |
| CHEMBL4685 | P14902 | Indoleamine 2,3-dioxygenase | 83.01% | 96.38% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 82.63% | 98.59% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 82.58% | 89.00% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 82.56% | 96.11% |
| CHEMBL4660 | P28907 | Lymphocyte differentiation antigen CD38 | 82.53% | 95.27% |
| CHEMBL2189110 | Q15910 | Histone-lysine N-methyltransferase EZH2 | 81.83% | 97.50% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 81.28% | 93.56% |
| CHEMBL5852 | Q96P65 | Pyroglutamylated RFamide peptide receptor | 81.03% | 85.00% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 80.71% | 98.05% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 80.62% | 97.50% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 80.47% | 89.50% |
| CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 80.02% | 86.33% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 14769215 |
| LOTUS | LTS0260441 |
| wikiData | Q105219340 |